All Pharma News
Veru to Present at the GLP-1 Based Therapeutics Summit

Veru to Present at the GLP-1 Based Therapeutics Summit
GLOBENEWSWIRE
02 May 2024
Share Share
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
GLOBENEWSWIRE
01 May 2024
Share Share
Veru Enrolls First Patients In Enobosarm-Semaglutide Weight Loss Trial

Veru Enrolls First Patients In Enobosarm-Semaglutide Weight Loss Trial
GLOBENEWSWIRE
30 Apr 2024
Share Share
Veru Presents at AACE 2024 Annual Meeting

Veru Presents at AACE 2024 Annual Meeting
GLOBENEWSWIRE
25 Apr 2024
Share Share
Veru Announces Date of 2024 Annual Meeting of Shareholders

Veru Announces Date of 2024 Annual Meeting of Shareholders
GLOBENEWSWIRE
01 Apr 2024
Share Share
Veru Reschedules Annual Meeting of Shareholders

Veru Reschedules Annual Meeting of Shareholders
GLOBENEWSWIRE
22 Mar 2024
Share Share
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor
GLOBENEWSWIRE
12 Mar 2024
Share Share
Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report

Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report
GLOBENEWSWIRE
27 Feb 2024
Share Share
Veru Announces New Scientific Advisory Board for its Enobosarm Program

Veru Announces New Scientific Advisory Board for its Enobosarm Program
GLOBENEWSWIRE
20 Feb 2024
Share Share
Veru Reports Fiscal 2024 First Quarter Financial Highlights

Veru Reports Fiscal 2024 First Quarter Financial Highlights
GLOBENEWSWIRE
08 Feb 2024
Share Share